| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
University of Würzburg (H.-Y.L., M.J.H., H.M.R.), Institute for Virology and Immunobiology, 97078 Würzburg, Germany; University of Göttingen (J.v.d.B., H.M.R.), Medical School, Department of Cellular and Molecular Immunology, 37073 Göttingen, Germany; and University of Würzburg (M.F., B.A.), Department of Internal Medicine I, Endocrine and Diabetes Unit, 97080 Würzburg, Germany
Address all correspondence and requests for reprints to: Prof. Dr. Holger Reichardt, University of Göttingen, Medical School, Department of Cellular and Molecular Immunology, Humboldtallee 34, 37073 Göttingen, Germany. E-mail: hreichardt{at}med.uni-goettingen.de.
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The mineralocorticoid receptor (MR) is involved in controlling the salt-water balance, neuronal excitability, and heart function. In kidney and colon, the adrenocortical hormone aldosterone induces sodium reabsorption and thereby regulates extracellular fluid volume and blood pressure (8). Loss-of-function mutations of the MR cause pseudohypoaldosteronism type I (PHA I) in humans, which is characterized by increased plasma renin activity (PRA) and an altered Na+/K+ balance. Similar physiological deficits are seen in newborn MR knockout mice, but their early lethality precluded more detailed analyses (9). In contrast, mice selectively lacking the MR in the kidney only show a mild phenotype, presumably due to an incomplete deletion in aldosterone target cells (10, 11). To generate an alternative model of PHA I, we silenced the MR in transgenic rats by lentiviral expression of a specific shRNA (12). At 3 wk of age, MR levels were strongly decreased, the body weight reduced, circulating aldosterone and PRA increased, and expression of MR target genes altered. Most importantly, we also obtained a number of adult MR knockdown rats exhibiting typical defects in endocrine and electrolyte homeostasis. We suggest that this technique is an attractive option to generate rats with diminished gene expression that may serve as models for human diseases.
| RESULTS |
|---|
|
|
|---|
|
|
First, we investigated MR mRNA levels in kidney and hippocampus by quantitative PCR. Expression of the highly related glucocorticoid receptor (GR) served as a control. Analysis of 33 transgenic rats revealed a reduction of MR mRNA expression by 75% on average, whereas GR levels were unaltered (Fig. 2A
). Interestingly, we observed a great diversity of MR levels ranging from a reduction by less than half to an almost complete loss. As previously reported, the copy number and integration site of the provirus strongly impact on the level of transgene expression (13), thereby explaining the variability in gene silencing.
|
Endocrine Homeostasis Is Disrupted in Young MR Knockdown Rats
Previous analyses have shown that MR knockout mice die shortly after birth due to a severe disturbance of the salt-water balance (9). Their phenotype is characterized by growth retardation, elevated serum aldosterone levels, and increased PRA, two hormones involved in the regulation of sodium reabsorption in the kidney. To investigate whether MR knockdown rats show similar physiological alterations, we first analyzed them at approximately 3 wk of age. Strikingly, some of the pups were lost around 2 wk after birth. We suspect that similar to homozygous MR knockout mice, the silencing was too efficient in these transgenic rats to be compatible with life. However, most of the offspring survived and could be analyzed. First, we observed a significantly lower body weight in the transgenic rats as compared with wild-type littermates (Fig. 3A
). Although there was a considerable degree of heterogeneity among the offspring, body weight reduction correlated with the degree of MR mRNA reduction (Fig. 3B
). This suggests that the phenotype of the MR knockdown rats is a direct consequence of gene silencing by RNAi. In addition, the 3-wk-old MR knockdown rats had elevated PRA and serum aldosterone levels (Fig. 3C
). Again, there was a significant inverse correlation between the degree to which MR expression was diminished and the observed increase in aldosterone (Fig. 3D
). We conclude that endocrine homeostasis directly depends on the MR dosage.
|
Analysis of Adult MR Knockdown Rats
One advantage of the RNAi technology and the concomitant incomplete gene silencing is the ability to circumvent an early lethal phenotype often encountered in conventional knockout mice (5). Because MR-deficient mice die shortly after birth (9), we were curious whether adult MR knockdown rats could be obtained that had a sufficient degree of gene silencing to result in an appreciable physiological phenotype.
MR knockdown rats were identified by PCR based on the presence of the provirus in the genome and killed at an age of 3–6 months. As a measure for an actively transcribed transgene, we analyzed DsRed expression. Interestingly, red fluorescence in the pancreas could be detected only in about half of the adult MR knockdown rats (Fig. 4A
), which was also true for the analysis of the DsRed protein in kidney by Western blot (Fig. 4B
). To determine whether the siMR transgenic rats show any discernable endocrine phenotype and whether DsRed expression correlates with PRA and serum aldosterone levels, we divided them into two groups based on the traceability of red fluorescence. PRA was significantly elevated in rats expressing DsRed whereas the levels in the nonfluorescent rats were in the range of the wild-type controls (Fig. 4C
). Moreover, there was a correlation between serum aldosterone levels and PRA, confirming that endocrine homeostasis was only affected in DsRed-positive rats (Fig. 4C
). Thus, the provirus appears to be inactive in some of the transgenic animals while being functional in the rest.
Because the MR controls sodium reabsorption in epithelial tissues, we investigated electrolyte homeostasis in the kidney. In transgenic rats, Na+ plasma levels were decreased whereas K+ levels were increased (Fig. 4D
). Conversely, the concentration of sodium in urine was strongly elevated whereas potassium was not significantly affected (Fig. 4D
). Thus, adult MR knockdown rats indeed have a disturbed salt-water balance.
Finally, we examined ENaC activity in DsRed-positive siMR transgenic rats by investigating the effect of amiloride, a specific blocker of ENaC, on renal sodium reabsorption. To this end, the fractional excretion of sodium (FENa+) was determined before and 3 h after sc injection of amelioride. In line with the electrolyte measurements, FENa+ in knockdown rats was approximately twice as high as compared with controls under basal conditions (Fig. 4E
). As expected, amiloride increased FENa+ in wild-type rats. Importantly, the effect of amiloride in siMR transgenic rats was comparable (Fig. 4E
), indicating that renal ENaC activity was largely intact. In summary, our findings suggest that lentiviral RNAi allows establishment of adult MR knockdown rats with a phenotype reminiscent of MR-deficient mice and PHA I patients.
| DISCUSSION |
|---|
|
|
|---|
In our study we have identified a number of advantages as well as disadvantages of the knockdown technology using lentiviruses for the delivery of siRNAs. First, we found that the vector used in this study is able to specifically reduce gene expression. However, because the DsRed protein was not expressed in peripheral blood leukocytes, we were unable to judge the degree of mosaicism and to noninvasively control for the expression of the transgene. To overcome this problem, a different promoter should be used in future constructs. For that reason, we have recently generated shRNA-expressing transgenic rats with various lentiviral constructs utilizing the Ubiquitin C promoter and successfully demonstrated green and red fluorescence in all peripheral blood leukocytes (our unpublished data). Second, our study shows that the expression level of the siRNA and therefore the degree of gene silencing differs between individual knockdown rats and tissues. We have previously shown that both the proviral integration site in the founder rats and their copy number impact transgene expression (13). Therefore, MR levels and knockdown efficacy strongly depend on the identity and number of proviral integration sites transmitted from the founder rats to their offspring. Consequently, the level of gene expression must be separately determined for each animal. Although this complicates the analysis, it also reflects the heterogeneity seen in many genetic diseases and can be useful in mimicking human pathophysiology. Third, by comparing the phenotypic consequences of MR silencing in the transgenic rats with those published for MR knockout mice, we could demonstrate that similar effects are achieved using both approaches. This holds true for the observed growth retardation, the altered hormone levels, and the disturbed electrolyte homeostasis. We therefore believe that siMR rats are a useful model for human PHA I. Fourth, we were able to obtain a number of adult MR knockdown rats. Nevertheless, the fact that some of them have silenced the transgene hampers their analysis. Although it is impossible to assess the degree of gene inactivation in living animals, our results indicate that knockdown efficacy correlates with PRA. Therefore, transgenic rats can be selected for experimentation on the basis of their elevated hormone levels whereas expression of MR and DsRed are controlled afterward. Using this strategy, it should be feasible to perform physiological studies with adult rats. Nevertheless, we are currently working on an improved method circumventing this problem, i.e. we have evidence that silencing of the transgene is prevented when using a tetracyclin-inducible construct (our unpublished data).
MR knockdown rats exhibit some of the endocrine features also seen in PHA I patients or MR knockout mice. Suprisingly, however, mRNA levels of the bona fide MR target gene Sgk1 as well as the
-, β-, and
-subunits of ENaC were elevated despite diminished MR protein levels. It appears that up-regulation of those genes is a consequence of increased aldosterone secretion in the presence of the continuous expression of at least low receptor levels. In this respect our model differs from MR knockout mice in which no receptor protein is left at all (9). In contrast, ENaC activity as well as protein expression was unchanged in siMR transgenic rats. This indicates that transcriptional and posttranscriptional control of ENaC by the MR differs, and that the impaired renal sodium reabsorption observed in siMR transgenic rats is, at least in part, due to the deregulation of yet unidentified amiloride-insensitive channel proteins. Interestingly, mRNA expression of the intermediate-conductance potassium channel IK1/Kcnn4, which is believed to be regulated by aldosterone through nongenomic mechanisms, was diminished (16). It is therefore tempting to speculate that genomic and nongenomic effects of the MR are differently influenced by gene silencing.
In our view, MR knockdown rats have several advantages over the already existing mouse models. Due to the larger size and their closer proximity to humans, rats in general are often preferred for the analysis of kidney and heart physiology. In addition, partial gene silencing by RNAi allows circumvention of the early postnatal lethality observed in MR-deficient mice (9). Thus, our strategy allows, for the first time, obtaining adult animals with reduced MR expression that exhibit a pathology resembling PHA I. However, we admit that the lack of tissue specificity, which can only be achieved with the Cre-loxP system, is a drawback. On the other hand, such an approach is often impeded by the lack of suitable promoters to drive Cre expression. Whereas region specificity was achieved in forebrain-specific MR knockout mice, deletion of the MR in the principal cells of the kidney resulted in an unexpectedly mild phenotype. In this approach, Cre expression driven by the aquaporin 2 promoter did not fully match the expression pattern of the MR in the kidney (10, 11). Consequently, residual MR present in the distal tubular segment of the kidney resulted in normal sodium and potassium concentrations in plasma and urine under a standard diet. To our knowledge, adult siMR transgenic rats are therefore the only loss-of-function model for the MR characterized by a disturbed salt-water balance under normal conditions.
In summary, we have identified lentiviral RNAi in transgenic rats as a powerful technology by which to generate human disease models that allows combining the advantages of this species with the power of targeted gene silencing.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Virus Production and Concentration of Lentiviruses
Lentiviral particles were produced by transient cotransfection of the four plasmids pMDL/RRE, RSV-Rev, pMD2G-VSVG, and pDR-siMR into human embryonic kidney 293 T cells using the calcium-phosphate method (12). The supernatants containing the lentivirus were passed through a 0.45-µm filter, concentrated by ultracentrifugation at 25,000 rpm for 90 min at 4 C and resuspended in 20 µl PBS. The titer was determined by transducing HeLa cells followed by flow cytometric analysis of DsRed expression.
Transgenesis
Transgenic rats were generated as described previously (13). Of the concentrated lentiviral preparation, 10–100 pl were injected into the perivitelline space of fertilized single-cell embryos obtained from superovulated Crl:CD rats (Charles River, Sulzfeld, Germany). The injected zygotes were cultured overnight and transferred into the oviduct of pseudopregnant Crl:CD females. All animal experimentation was conducted in accord with standards of human animal care and approved by the Bavarian state authorities.
MR-Expressing HeLa Cells
HeLa cells were transduced with FUrMRW lentiviral particles and cultured for 5 d. The transduced cells were pooled and monitored for MR expression by Western blot. The FUrMRW vector had been cloned by inserting the full-length rat MR cDNA (a kind gift from Dr. Onno Meijer, Leiden, The Netherlands) into the BamHI site of the lentiviral vector FUW (14).
PCR and Western Blot Analyses
Total RNA was isolated and transcribed into cDNA as described elsewhere (20). Quantitative RT-PCR was performed using an iCycler instrument (Bio-Rad Laboratories, München, Germany). The sequences of the gene-specific primers are available upon request. Transgenic rats were genotyped by conventional PCR using genomic tail DNA digested with Proteinase K in TNES buffer (10 mM Tris, pH 7.5; 0.4 M NaCl, 0.1 M EDTA; 0.6% SDS; 100 µg/ml Proteinase K). Amplification was done at 64 C for 30 cycles using two primers specific for the lentiviral vector: 5'-AGGAAACTCACCCTAACTGTA A-3' and 5'-CGGCCGCTTAAGCTTGGA AC-3'.
Protein extracts from cells and tissues were prepared in radioimmune precipitation assay lysis buffer, separated on a SDS-PAGE gel, transferred to a polyvinylidine difluoride membrane, and detected using the following antibodies: anti-MR (H-300; Santa Cruz Biotechnology, Heidelberg, Germany), anti-GR (M-20; Santa Cruz), anti-β-tubulin (clone TUB2.1, Sigma Aldrich, Taufkirchen, Germany) and anti-βENaC (H-190; Santa Cruz). Quantification of band intensities was achieved using the GelPro Analyzer 4.5 software (Media Cybernetics, Silver Spring, MD).
Northern Blot Analysis of siRNA Expression
Total RNA (15 mg) was electrophoresed on a 10% Tris-borate, EDTA-urea polyacrylamide gel, transferred onto a nylon membrane, and hybridized to oligonucleotide probes labeled by [32P]
-ATP. The three probes corresponded to the 19-nucleotide siRNA sequence specific for the MR (in sense or antisense orientation) and a sequence complementary to the 5S-rRNA (used as a control). The sequences of the oligos were as follows: 5'-GACAATAGTCGGTCTGGGA-3' (siMR, sense); 5'-TCCCAGACCGACTATTGTC-3' (siMR, antisense); 5'-CCCGATCCTGCTTAGCTTCCG-3' (5S rRNA).
Hormone and Electrolyte Measurements
PRA and serum aldosterone levels were determined by RIA using commercially available kits (RENCTK, DiaSorin, Dietzenbach, Germany and DPC Biermann, Bad Nauheim, Germany). The intraassay and interassay coefficients of variation were below 8% and 12%, respectively. PRA was measured on the basis of angiotensin I formation. Plasma and urine concentrations of Na+ and K+ were measured with standard ion-selective electrodes using samples collected in the morning. Creatinine levels were determined using a standard enzymatic test (Cobas Integra, Roche Diagnostics, Mannheim, Germany). The values obtained are in concordance with those published by The National BioResource Project for the Rat in Japan (www.anim.med.kyoto-u.ac.jp).
ENaC Activity Measurement
Plasma and urine samples were collected before and 3 h after amiloride treatment. To this end, 5 mg/kg amiloride hydrochloride (Sigma), dissolved in distilled water at a concentration of 50 mg/ml, were administered sc. The fractional excretion of sodium (FENA+) was determined based on Na+ and creatinine levels in plasma and urine using the following equation: FENA+ = (Na+U x CreaP)/(Na+P x CreaU).
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
Disclosure Statement: The authors of this manuscript have nothing to declare.
First Published Online March 12, 2008
1 H.-Y.L. and J.v.d.B. contributed equally to this work and should both be considered as first authors. ![]()
Abbreviations: DsRed, Discosoma sp. red fluorescent protein; GR, glucocorticoid receptor; MR, mineralocorticoid receptor; PHA I, pseudohypoaldosteronism type I; PRA, plasma renin activity; RNAi, RNA interference; shRNA, short hairpin RNA; siMR, short interfering MR; siRNA, short interfering RNA.
Received for publication September 5, 2007. Accepted for publication March 3, 2008.
| REFERENCES |
|---|
|
|
|---|
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
M. J. Herold, J. van den Brandt, J. Seibler, and H. M. Reichardt Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats PNAS, November 25, 2008; 105(47): 18507 - 18512. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |